Defibrillators Market Share, Size, Demand, Key Players by Forecast 2030

Global Defibrillators Market: Overview

The global defibrillators market was worth USD 11.4 billion in 2021 and is poised to reach a valuation of USD 26.23 billion by 2030, registering a CAGR of 9.7% over the forecast period of 2022-2030. 

Devices that send an electric pulse to the heart to normalise an irregular heartbeat are known as defibrillators. They are mostly employed to stop arrhythmia, which results in irregular heartbeat. External and implanted defibrillators are the most frequently utilised types.

Cardiovascular illnesses are becoming more widespread, healthcare costs are rising, and this industry's technological breakthroughs are accelerating, all of which are favourably affecting the market's dynamics.

Additionally, the ageing population is growing, the need for high-quality healthcare is increasing, and there are more programmes than ever before raising public awareness of the use and advantages of defibrillators.

Request a sample copy of Defibrillators Market:- https://wemarketresearch.com/sample-request/defibrillators-market/117/

Global Defibrillators Market: Segmental Analysis

By Key Players

• Abbott
• Boston Scientific Corporation
• BIOTRONIK SE & Co. KG
• MicroPort Scientific Corporation
• Koninklijke Philips N.V.
• Stryker Corporation
• ZOLL Medical Corporation (Asahi Kasei)
• Nihon Kohden Corporation
• Schiller AG
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
• LivaNova PLC

By Product:

• Implantable Defibrillators

o   Transvenous Implantable Cardioverter Defibrillator (T-ICDs)

o   Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)

o   Cardiac Resynchronization Therapy- Defibrillator (CRT-D)

• External Defibrillators

o   Manual External Defibrillator

o   Automated External Defibrillator (AEDs)

o   Wearable Cardioverter Defibrillator (WCDs)

The implantable defibrillators segment is slated to garner significant returns over the stipulated timeline. This is ascribed to the growing pervasiveness of chronic cardiac disorders and technological advancements in healthcare devices sector.

By Patient Type:

• 
  Adult
  • Pediatrics

The adult segment is expected to capture a substantial revenue share over 2022-2030. This is attributable to the growing cardiac arrest rates among the adult population.

By End User:

• 
  Hospitals
  • Clinics and Cardiac centers
  • Pre-hospital care settings
  • Public access markets
  • Home care settings
  • Alternate care facilities

The hospital segment is predicted to grow considerably over the esteemed time period owing to the availability of skilled technicians and doctors to treat the patients admitted with cardiac disorders.

Global Defibrillators Market: Geographical Ambit

The major regions constituting the geographical terrain of this industry sphere are North America, Middle East & Africa, Europe, Latin America, and Asia Pacific. Among these, Asia Pacific is poised to record exponential growth over 2022-2030. This is credited to the growing incidences of cardiovascular disorders, developments in healthcare infrastructure, and rise in geriatric population.

Frequently Asked Questions

What is the growth rate projection for Global Defibrillators Market over 2022-2030?

What are the growth determinants of Global Defibrillators Market?

What are the major segments covered in the Global Defibrillators Market?

What are the key regions constituting the geographical ambit of Global Defibrillators Market?

Which is the fastest growing region in Global Defibrillators Market?